BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31624299)

  • 1. Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis.
    Su CW; Chang YC; Chien MH; Hsieh YH; Chen MK; Lin CW; Yang SF
    Cell Death Dis; 2019 Oct; 10(11):793. PubMed ID: 31624299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peperomin E Induces Promoter Hypomethylation of Metastatic-Suppressor Genes and Attenuates Metastasis in Poorly Differentiated Gastric Cancer.
    Wanga XZ; Gu JL; Gao M; Bian Y; Liang JY; Wen HM; Wu H
    Cell Physiol Biochem; 2018; 50(6):2341-2364. PubMed ID: 30423554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation and expression of TIMP3 gene in gastric cancer.
    Guan Z; Zhang J; Song S; Dai D
    Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
    Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
    Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic Anhydrase III Promotes Cell Migration and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Chu YH; Su CW; Hsieh YS; Chen PN; Lin CW; Yang SF
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylation of TIMP2 and TIMP3 Inhibits Cell Proliferation, Migration, and Invasion in Pituitary Adenomas.
    Yang Y; Huang F; Wu X; Huang C; Li Y
    Discov Med; 2024 May; 36(184):971-980. PubMed ID: 38798256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter Hypermethylation of Tumor-Suppressor Genes
    Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-κB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition.
    Hsieh MJ; Chen JC; Yang WE; Chien SY; Chen MK; Lo YS; Hsi YT; Chuang YC; Lin CC; Yang SF
    Biochem Pharmacol; 2017 Apr; 130():10-20. PubMed ID: 28131848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
    Anania MC; Sensi M; Radaelli E; Miranda C; Vizioli MG; Pagliardini S; Favini E; Cleris L; Supino R; Formelli F; Borrello MG; Pierotti MA; Greco A
    Oncogene; 2011 Jul; 30(27):3011-23. PubMed ID: 21339735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of methylation markers for diagnosis of oral cavity cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
    Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression.
    Su CW; Su BF; Chiang WL; Yang SF; Chen MK; Lin CW
    Int J Med Sci; 2017; 14(1):37-44. PubMed ID: 28138307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.
    Kornfeld JW; Meder S; Wohlberg M; Friedrich RE; Rau T; Riethdorf L; Löning T; Pantel K; Riethdorf S
    Br J Cancer; 2011 Jan; 104(1):138-45. PubMed ID: 21102583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.
    Su CW; Huang YW; Chen MK; Su SC; Yang SF; Lin CW
    Medicine (Baltimore); 2015 Nov; 94(46):e2092. PubMed ID: 26579821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells.
    Kong L; Zhang P; Li W; Yang Y; Tian Y; Wang X; Chen S; Yang Y; Huang T; Zhao T; Tang L; Su B; Li F; Liu XS; Zhang F
    Oncotarget; 2016 May; 7(19):27959-74. PubMed ID: 27058897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.
    Zhang H; Jiang S; Guo L; Li X
    J Cell Mol Med; 2019 Apr; 23(4):2813-2821. PubMed ID: 30734471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypomethylation of TIMP3 is associated with pre-eclampsia in a Chinese population.
    Xiang Y; Zhang X; Li Q; Xu J; Zhou X; Wang T; Xing Q; Liu Y; Wang L; He L; Zhao X
    Mol Hum Reprod; 2013 Mar; 19(3):153-9. PubMed ID: 23172037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
    Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
    BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.